News Contact Location Quality Technology Custom Manufacturing Products

Successful FDA Inspection

Dear Stakeholders,

This is to inform you that our site in Radebeul, Germany, was inspected by the US Food and Drug Administration (US-FDA) from 25. – 29. April 2016.
The audit has covered quality systems, equipment and facilities, materials, production, packaging, labeling and laboratory controls.
We are proud to announce that the inspection was concluded without the issue of a form 483.
This gives the evidence and proves again the continuous commitment of Arevipharma GmbH to operate in full compliance with the guidelines of good manufacturing practice (GMP) and maintain excellent quality standards.

Yours Sincerely

Dr. Hendrik Baumann
Chief Executive Officer

Arevipharma GmbH
Meißner Straße 35
D-01445 Radebeul
Telefon: +49 (0)351 8314-0
Telefax: +49 (0)351 8314-2100
Herr Daniel Hoffmann
Herr Dr. Dirk Jung
Amtsgericht Dresden, HRB 23835
USt-IdNr.: DE 240935001
Privacy Statement
Copyright © 2020 • Arevipharma GmbH Generiert: 5 ms